An effective strategic planning and evaluation process is critical to the success of Roswell Park Cancer Institute (RPCI) in making progress towards the scientific, clinical, prevention and education missions. External and internal advisory groups provide exceptional guidance and recommendations to the CCSG Senior Leadership. Ongoing planning and evaluation is conducted through regular meetings of the CCSG External Advisory Board (EAB), program-specific EABs, Executive Council, CCSG Steering Committee, Shared Resource Advisory Committees, individual program meetings, and Institute Strategic Leadership Retreats (SLRs). Disease-Site Research Group (DSRG) meetings occur monthly and bring together preclinical and clinical investigators committed to the study of specific diseases. In addition, yearly Program and Institute-wide science retreats are held to bring together CCSG members and faculty colleagues to discuss and develop the collaborative research central to CCSG Programs. The next RPCI Science Retreat is scheduled for June 2013. Planning and Evaluation activities are critical components of successful operations at RPCI. With the use of external and internal resources, RPCI maintains exceptional science while expanding and advancing the fields of cancer research, treatment and care, and prevention. Funds requested in this application will be used to offset some of the costs of the annual CCSG EAB and program-specific EAB meetings, and the RPCI member retreat, while the remaining planning and evaluation activities will be supported by Institute resources

Public Health Relevance

These planning and evaluation activities are guided by the RPCI Strategic Plan (SP) which was developed through broad Institute faculty, staff and Board of Directors (BOD) participation. This plan laid out, based on detailed analytic information, the RPCI 10-year strategy. The SP was approved in 2009 by the BOD and is monitored specifically for progress quarterly (SLRs) and annually for overall direction. The three major components of the SP are: 1) Scientific Enhancement;2) Clinical Growth;3) Optimizing Operations.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Roswell Park Cancer Institute Corp
United States
Zip Code
Miller, James A; Harris, Kassem; Roche, Charles et al. (2018) Sarcopenia is a predictor of outcomes after lobectomy. J Thorac Dis 10:432-440
Fenstermaker, Robert A; Figel, Sheila A; Qiu, Jingxin et al. (2018) Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo. Clin Cancer Res 24:2642-2652
Bhat, Tariq A; Kalathil, Suresh Gopi; Bogner, Paul N et al. (2018) Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections. J Immunol 200:2927-2940
Merzianu, Mihai; Groman, Adrienne; Hutson, Alan et al. (2018) Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. Am J Clin Pathol 150:393-405
Qin, Bo; Llanos, Adana A M; Lin, Yong et al. (2018) Validity of self-reported weight, height, and body mass index among African American breast cancer survivors. J Cancer Surviv 12:460-468
Qiao, Guanxi; Chen, Minhui; Bucsek, Mark J et al. (2018) Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. Front Immunol 9:164
Muramatsu, Masashi; Akakura, Shin; Gao, Lingqiu et al. (2018) SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk. Oncotarget 9:33515-33527
Kumar, Sandeep; Inigo, Joseph R; Kumar, Rahul et al. (2018) Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Cancer Lett 413:82-93
Liu, Chunhong; Yu, Tao; Xing, Zhuo et al. (2018) Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors. Oncotarget 9:4773-4786
Cimato, Thomas R; Conway, Alexis; Nichols, Julianne et al. (2018) CD133 expression in circulating hematopoietic progenitor cells. Cytometry B Clin Cytom :

Showing the most recent 10 out of 1555 publications